(2009). Response to: The BRAIN TRIAL: a randomized, placebo controlledtrial of a Bradykinin B2 receptor antagonist (Anatibant) in patientswith traumatic brain injury - authors' reply. Trials, 10, 1.
Chicago Style (17th ed.) Citation"Response to: The BRAIN TRIAL: A Randomized, Placebo Controlledtrial of a Bradykinin B2 Receptor Antagonist (Anatibant) in Patientswith Traumatic Brain Injury - Authors' Reply." Trials 10 (2009): 1.
MLA (9th ed.) Citation"Response to: The BRAIN TRIAL: A Randomized, Placebo Controlledtrial of a Bradykinin B2 Receptor Antagonist (Anatibant) in Patientswith Traumatic Brain Injury - Authors' Reply." Trials, vol. 10, 2009, p. 1.
Warning: These citations may not always be 100% accurate.
